Search for: All records

Manganese ([Mn(CO) 3 ]) and rhenium tricarbonyl ([Re(CO) 3 ]) complexes represent a workhorse family of compounds with applications in a variety of fields. Here, the coordination, structural, and electrochemical properties of a family of mono- and bimetallic [Mn(CO) 3 ] and [Re(CO) 3 ] complexes are explored. In particular, a novel heterobimetallic complex featuring both [Mn(CO) 3 ] and [Re(CO) 3 ] units supported by 2,2′-bipyrimidine (bpm) has been synthesized, structurally characterized, and compared to the analogous monomeric and homobimetallic complexes. To enable a comprehensive structural analysis for the series of complexes, we have carried out new single crystal X-ray diffraction studies of seven compounds: Re(CO) 3 Cl(bpm), anti -[{Re(CO 3 )Cl} 2 (bpm)], Mn(CO) 3 Br(bpz) (bpz = 2,2′-bipyrazine), Mn(CO) 3 Br(bpm), syn - and anti -[{Mn(CO 3 )Br} 2 (bpm)], and syn -[Mn(CO 3 )Br(bpm)Re(CO) 3 Br]. Electrochemical studies reveal that the bimetallic complexes are reduced at much more positive potentials (Δ E ≥ 380 mV) compared to their monometallic analogues. This redox behavior is consistent with introduction of the second tricarbonyl unit which inductively withdraws electron density from the bridging, redox-active bpm ligand, resulting in more positive reduction potentials. [Re(CO 3 )Cl] 2 (bpm) was reduced with cobaltocene; the electron paramagnetic resonance spectrum of the product exhibits an isotropic signal (near g = 2) characteristic of a ligand-centered bpm radical. Our findings highlight the facile synthesis as well as the structural characteristics and unique electrochemical behavior of this family of complexes. 

Catalysis using earth abundant metals is an important goal due to the relative scarcity and expense of precious metal catalysts. It would be even more beneficial to use earth abundant catalysts for the synthesis of common pharmaceutical structural motifs such as pyrrolidine and pyridine. Thus, developing titanium catalysts for asymmetric ring closing hydroamination is a valuable goal. In this work, four sterically encumbered chiral sulfonamides derived from naturally occurring amino acids were prepared. These compounds undergo protonolysis reactions with Ti(NMe 2 ) 4 or Ta(NMe 2 ) 5 to give monomeric complexes as determined by both DOSY NMR and X-ray crystallography. The resulting complexes are active for the ring closing hydroamination hepta-4,5-dienylamine to give a mixture of tetrahydropyridine and pyrrolidine products. However, the titanium complexes convert 6-methylhepta-4,5-dienylamine exclusively to 2-(2-methylpropenyl)pyrrolidine in higher enantioselectivity than those previously reported, with enantiomeric excesses ranging from 18-24%. The corresponding tantalum complexes were more selective with enantiomeric excesses ranging from 33-39%. 

Alkylation of d - or l -phenylalanine or valine alkyl esters was carried out using methyl or phenyl Grignard reagents. Subsequent condensation with salicylaldehyde, 3,5-di- tert -butylsalicylaldehyde, or 5-fluorosalicylaldehyde formed tridentate, X 2 L type, Schiff base ligands. Chiral shift NMR confirmed retention of stereochemistry during synthesis. X-ray crystal structures of four of the ligands show either inter- or intramolecular hydrogen bonding interactions. The ligands coordinate to the titanium reagents Ti(NMe 2 ) 4 or TiCl(NMe 2 ) 3 by protonolysis and displacement of two equivalents of HNMe 2 . The crystal structure of one example of Ti(X 2 L)Cl(NMe 2 ) was determined and the complex has a distorted square pyramidal geometry with an axial NMe 2 ligand. The bis-dimethylamide complexes are active catalysts for the ring closing hydroamination of di- and trisubstituted aminoallenes. The reaction of hepta-4,5-dienylamine at 135 °C with 5 mol% catalyst gives a mixture of 6-ethyl-2,3,4,5-tetrahydropyridine (40–72%) and both Z - and E -2-propenyl-pyrrolidine (25–52%). The ring closing reaction of 6-methyl-hepta-4,5-dienylamine at 135 °C with 5 mol% catalyst gives exclusively 2-(2-methyl-propenyl)-pyrrolidine. The pyrrolidine products are obtained with enantiomeric excesses up to 17%.